ES2058827T3 - Uso de soluciones de atelocolageno y poliholosidos, por ejemplo glicosaminoglicanos, para la fabricacion de microcapsulas, a microcapsulas preparadas de esta manera, a procedimientos para la fabricacion de estas microcapsulas y a composiciones cosmeticas, farmaceuticas o alimenti - Google Patents

Uso de soluciones de atelocolageno y poliholosidos, por ejemplo glicosaminoglicanos, para la fabricacion de microcapsulas, a microcapsulas preparadas de esta manera, a procedimientos para la fabricacion de estas microcapsulas y a composiciones cosmeticas, farmaceuticas o alimenti

Info

Publication number
ES2058827T3
ES2058827T3 ES90400030T ES90400030T ES2058827T3 ES 2058827 T3 ES2058827 T3 ES 2058827T3 ES 90400030 T ES90400030 T ES 90400030T ES 90400030 T ES90400030 T ES 90400030T ES 2058827 T3 ES2058827 T3 ES 2058827T3
Authority
ES
Spain
Prior art keywords
microcapsules
manufacture
polyholosides
atelocollagen
example glycosaminoglycans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90400030T
Other languages
English (en)
Inventor
Marie-Christine Levy
Marie-Christine Andry
Alain Huc
Chantal Buffevant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Coletica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8901221A external-priority patent/FR2642329B1/fr
Application filed by Coletica SA filed Critical Coletica SA
Application granted granted Critical
Publication of ES2058827T3 publication Critical patent/ES2058827T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/04Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/10Complex coacervation, i.e. interaction of oppositely charged particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

LA INVENCION SE REFIERE A MICROCAPSULAS CON UNA PARED MEZCLADA DE POLIHOLOSIDOS Y ATELOCOLAGENOS RETICULADOS. POR EJEMPLO GLICOSAMINOCLICANOS, Y A PROCEDIMIENTOS PARA LA OBTENCION DE TALES MICROCAPSULAS. DE CONFORMIDAD CON LA INVENCION, LAS MICROCAPSULAS COMPRENDEN UNA PARED MEZCLADA DE ATELOCOLAGENO Y POLIHOLOSIDOS RETICULADOS, POR EJEMPLO, GLICOSAMINOGLICANOS, ESTANDO LA PROPORCION DE POLIHOLOSIDOS, POR EJEMPLO GLICOSAMINOGLICANOS, RESPECTO A LOS ATELOCOLAGENOS, PREFERENTEMENTE ENTRE 18 Y 50% POR PESO. ESTAS MICROCAPSULAS PUEDEN OBTENERSE MEDIANTE UN PROCEDIMIENTO QUE IMPLICA LA RETICULACION INTERFACIAL, O MEDIANTE LA EXTRUSION DE UN FLUJO LAMINAR, QUE SE ROMPE MEDIANTE VIBRACIONES EN GOTAS INDIVIDUALES, QUE CAEN DENTRO DE UN BAÑO DE RETICULACION. ESTAS MICROCAPSULAS SON BIOCOMPATIBLES EN VIRTUD DE LA PRESENCIA DE ATELOCOLAGENO, QUE TIENE LA MAYOR PARTE DE LAS PROPIEDADES VENTAJOSAS DEL COLAGENO, ES DECIR, UNA MUY BAJA ANTIGENICIDAD Y UNA PERFECTA BIODEGRADABILIDAD. SON, POR CONSIGUIENTE,PARTICULARMENTE ADECUADAS PARA LA FABRICACION DE COMPOSICIONES COSMETICAS, FARMACEUTICAS O ALIMENTICIAS.
ES90400030T 1989-01-31 1990-01-05 Uso de soluciones de atelocolageno y poliholosidos, por ejemplo glicosaminoglicanos, para la fabricacion de microcapsulas, a microcapsulas preparadas de esta manera, a procedimientos para la fabricacion de estas microcapsulas y a composiciones cosmeticas, farmaceuticas o alimenti Expired - Lifetime ES2058827T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8901221A FR2642329B1 (fr) 1989-01-31 1989-01-31 Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant
US33671189A 1989-04-12 1989-04-12

Publications (1)

Publication Number Publication Date
ES2058827T3 true ES2058827T3 (es) 1994-11-01

Family

ID=26227140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90400030T Expired - Lifetime ES2058827T3 (es) 1989-01-31 1990-01-05 Uso de soluciones de atelocolageno y poliholosidos, por ejemplo glicosaminoglicanos, para la fabricacion de microcapsulas, a microcapsulas preparadas de esta manera, a procedimientos para la fabricacion de estas microcapsulas y a composiciones cosmeticas, farmaceuticas o alimenti

Country Status (9)

Country Link
EP (1) EP0381543B1 (es)
JP (1) JP2534921B2 (es)
KR (1) KR0163171B1 (es)
AT (1) ATE89766T1 (es)
AU (1) AU633866B2 (es)
CA (1) CA2009065C (es)
DE (1) DE69001683T2 (es)
DK (1) DK0381543T3 (es)
ES (1) ES2058827T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652741B1 (fr) * 1989-10-10 1994-03-04 Laboratoires Care System Composition antimicrobienne pour application sur la peau, applications comme deodorant corporel et bactericide cutane.
FR2665374B1 (fr) * 1990-08-03 1992-12-04 Bioetica Sa Microcapsules a paroi mixte d'atelocollagene et de polyholosides coagulee par un cation bivalent et procede de fabrication de ces microcapsules et des compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant.
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
FR2686250A1 (fr) * 1992-01-16 1993-07-23 Coletica Compositions injectables contenant en suspension des microcapsules a base de collagene, leur utilisation biomedicale et des compositions pharmaceutiques.
US5658593A (en) * 1992-01-16 1997-08-19 Coletica Injectable compositions containing collagen microcapsules
FR2686249A1 (fr) * 1992-01-16 1993-07-23 Olivier Josette Preparation a usage cutane a base de liposomes.
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
GB2281861B (en) * 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
FR2730636B1 (fr) * 1995-02-16 1997-04-25 Cosmart Ag Huile vegetale naturelle enrichie en ozonides, compositions cosmetiques ou pharmaceutiques la contenant et utilisations
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
CA2217134A1 (en) * 1996-10-09 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Sustained release formulation
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
KR100505322B1 (ko) * 1997-07-15 2005-08-04 콜티카 가교화된 식물 단백질 입자, 특히 마이크로입자 또는 나노입자의제조방법 및 이들을 포함하는 화장품, 의약품 또는 식품 조성물
FR2766090B1 (fr) * 1997-07-15 1999-10-08 Coletica Particules, en particulier micro- ou nanoparticules de proteines vegetales reticulees, leur procede de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
US6037481A (en) * 1997-08-08 2000-03-14 Industria E Comercio De Cosmeticos Natura Ltda Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
AUPO888097A0 (en) * 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
DE19752585B4 (de) * 1997-11-27 2007-06-28 Inotech Ag Vorrichtung und Verfahren zum Verkapseln von mikrobiellen, pflanzlichen und tierischen Zellen bzw. von biologischen und chemischen Substanzen
BR9803936A (pt) * 1998-09-08 2000-04-04 Cosmeticos Natural Ind Com Processo e composição para aumentar a ação de vitamina a na atividade celular de um indivìduo e uso de vitamina c.
DE60140874D1 (de) * 2000-08-17 2010-02-04 Chugai Pharmaceutical Co Ltd Verfahren zum herstellen einer nahtlosen kapsel
FR2829947B1 (fr) * 2001-09-21 2004-10-15 Chiralsep Sarl Reseau polymere tridimensionnel reticule, son procede de preparation, materiau support comportant ce reseau et leurs utilisations
FR2870738B1 (fr) * 2004-05-26 2006-07-28 Oreal Composition cosmetique comprenant des microspheres
KR102173628B1 (ko) 2019-03-07 2020-11-03 서강인 압출 스낵의 진공탈기를 이용하는 팽화 장치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5814253B2 (ja) * 1974-04-10 1983-03-18 カンザキセイシ カブシキガイシヤ ビシヨウカプセルノ セイゾウホウホウ
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention
JPS6422254A (en) * 1987-07-20 1989-01-25 Terumo Corp Injury covering material

Also Published As

Publication number Publication date
KR900011457A (ko) 1990-08-01
CA2009065A1 (en) 1990-07-31
DE69001683T2 (de) 1993-12-02
EP0381543B1 (en) 1993-05-26
AU4886490A (en) 1990-08-09
EP0381543A1 (en) 1990-08-08
KR0163171B1 (ko) 1998-12-01
DE69001683D1 (de) 1993-07-01
JP2534921B2 (ja) 1996-09-18
DK0381543T3 (da) 1993-10-04
JPH02229111A (ja) 1990-09-11
ATE89766T1 (de) 1993-06-15
AU633866B2 (en) 1993-02-11
CA2009065C (en) 1999-08-24

Similar Documents

Publication Publication Date Title
ES2058827T3 (es) Uso de soluciones de atelocolageno y poliholosidos, por ejemplo glicosaminoglicanos, para la fabricacion de microcapsulas, a microcapsulas preparadas de esta manera, a procedimientos para la fabricacion de estas microcapsulas y a composiciones cosmeticas, farmaceuticas o alimenti
BR9307431A (pt) Composição à base de água formadora de pelìcula curável
DE69332222T2 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
DE69004625D1 (de) Verfahren zur Herstellung von strahlungsvernetzbaren Überzügen, strahlungsvernetzbare Zusammensetzungen und Carbonate.
CA2314151A1 (en) Polyhydroxyalkanoate compositions having controlled degradation rates
CA2270599A1 (en) Chemical modification of biomedical materials with genipin
ATE47669T1 (de) Chirurgische nahtmaterialien.
DE69014146D1 (de) Verfahren zur Herstellung von Polyester-Polyepoxid-Zusammensetzungen mit hoher Schmelzviskosität.
ATE104325T1 (de) Waessrige ueberzugsmasse, deren herstellung und verwendung.
BR9000217A (pt) Processo para a producao de uma composicao de pre-polimero de organossilicio e uso das composicoes de pre-polimero de organossilicio
DE60131113D1 (de) Verfahren zur Herstellung von Formkörper aus Stärkehydrolysaten mit niedrigem DE und/oder mit diesen Stärkehydrolysaten beschichtet
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ES2025572T3 (es) Procedimiento para fabricar adhesivos derivados de proteinas polifenolicas bioadhesivas.
CA2010778A1 (en) Bioactive agents, compositions and materials comprising said bioactive agents
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
CA2016968A1 (en) Air freshener composition
ATE74487T1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
PT88929A (pt) Processo para a preparacao de uma composicao detergente liquida aquosa tixotropica para lavagem automatica de louca,contendo um agente antiformacao de pelicula a base de alumina ou de dioxido de titanio
DE68920777D1 (de) Fluor enthaltende Copolymere, Verfahren zur Herstellung davon und Vernetzungszusammensetzungen.
FR2642329B1 (fr) Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant
FR2651230B1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et applications comme medicaments.
DE382180T1 (de) Derivate von thiazolidin-4-carbonsaeure, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE77746T1 (de) Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure, deren herstellung sowie deren verwendung zur herstellung von arzneimitteln mit einer die thrombozyten-aggregation hemmenden wirkung.
DE59800821D1 (de) Safran oder Safranbestandteile enthaltende Zusammensetzungen, Verfahren zur Herstellung derselben und Verwendungen derselben
EP0362731A3 (de) Verfahren zur Herstellung von Arzneimittelwirkstoff-Partikeln mit verbesserten Fliess-, Lager- und Formulierungseigenschaften sowie Arzneimittel, die diese Arzneimittelwirkstoff-Partikeln enthalten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381543

Country of ref document: ES